160 related articles for article (PubMed ID: 7093956)
1. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
Pallavicini MG; Gray JW; Folstad LJ
Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
[TBL] [Abstract][Full Text] [Related]
2. Cytokinetic properties of asynchronous and cytosine arabinoside perturbed murine tumors measured by simultaneous bromodeoxyuridine/DNA analyses.
Pallavicini MG; Summers LJ; Dolbeare FD; Gray JW
Cytometry; 1985 Nov; 6(6):602-10. PubMed ID: 4064840
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
Fietkau R; Friede H; Maurer-Schultze B
Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
6. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.
Alabaster O; Bunnag B
Cancer Res; 1976 Aug; 36(8):2744-9. PubMed ID: 1277184
[TBL] [Abstract][Full Text] [Related]
7. Enhanced radiation lethality in partially synchronized solid mouse tumors.
Todoroki T; Koike S; Tsunemoto H; Watanabe I
Cancer Res; 1982 Dec; 42(12):5231-5. PubMed ID: 7139626
[TBL] [Abstract][Full Text] [Related]
8. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
Momparler RL; Goodman J; Karon M
Cancer Res; 1975 Oct; 35(10):2853-7. PubMed ID: 50882
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
10. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
Karp JE; Donehower RC; Dole GB; Burke PJ
Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
[TBL] [Abstract][Full Text] [Related]
12. The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells.
Jones PA; Baker MS; Benedict WF
Cancer Res; 1976 Oct; 36(10):3789-97. PubMed ID: 986242
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
Rauscher F; Cadman E
Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
[TBL] [Abstract][Full Text] [Related]
15. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
Fram RJ; Kufe DW
Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
Schwartz SA; Morgenstern B; Capizzi RL
Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
18. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
Smets LA; Homan-Blok J
Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
Stoehr M; Friedel G; Engel P; Goerttler K; Futterman G
Arzneimittelforschung; 1984; 34(4):451-4. PubMed ID: 6204650
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]